Metropolis eyes SRL in spinoff dealMetropolis was exploring a consolidation deal which could make it the largest diagnostics chain in Asia’s third-largest economy, sources sa...
Demerger of diagnostics business makes Fortis a healthy choiceThe demerger arrangement of SRL will involve transferring the diagnostics business to Fortis Malar.
2 wealth creation ideas from Avinnash GorakssakarCapital First has maintained a very strong asset quality profile of gross NPAs of below 0.95%
Fortis' diagnostic arm may be listed on bourses by AugustThe diagnostics segment has been a favourite among investors with the stellar listings of both Dr Lal PathLabs and Thyrocare.
Fortis Healthcare to vertically demerge SRL DiagnosticsThe move aimed at giving an exit route to the PE Investors, who together own 34% stake in the company, two people familiar with the develop...
SRL Diagnostics to invest Rs 300 crore in 5 years to expand networkWith plethora of unaccredited labs in these cities, such initiatives will also help raise the benchmark in diagnostic services in tier II a...
Baring Asia, other PEs in talks to buy stake in SRL DiagnosticsThe SRL stake sale had previously attracted interest from a diverse set of buyout and sovereign wealth funds, including Warburg Pincus and ...
SRL Diagnostics may see exit of PE investors Avigo Capital, Jacob Ballas and IFCPrivate equity investors Avigo Capital, Jacob Ballas and IFC are likely to exit SRL Diagnostics, a subsidiary of hospital chain Fortis Heal...
SRL Diagnostics lines up Rs 100 crore to add 100 labs by 2016-endAt present, SRL offers over 3,500 types of tests and conducts more than 107,000 tests in a day, ranging from simple to high-end ones.
- SRL in talks with 6 state govts for PPP model diagnostic labs
Leading diagnostic chain SRL is in talks with six state governments in the country to start labs at government hospitals.
Practo adds diagnostic center search into its fold of servicesPracto now has around 4,000 labs across the 8 cities including chains such as Thyrocare, Suburban Diagnostics, SRL Labs, Metropolis and oth...
SRL Diagnostics plans to double headcount in North EastSRL Diagnostics today said it plans to more than double its headcount in North East to 300 employees over the next five years.
SRL Diagnostics plans to open labs in African countriesThe company will tie up with a local partner to set up reference laboratories and run for 5-10 years in Kenya, Tanzania, Mozambique and Uga...
Wipro implements solution at SRL DiagnosticsWipro today said it has implemented customer relationship management (CRM) solution at SRL Diagnostics to help transform its customer care ...
- Singh bros may buy Piramal’s 10% in SRL ahead of public issue
The promoters of Super Religare Laboratories Malvinder and Shivinder Singh may buyout Piramal Heathcare’s 10% stake in the country’s larges...
- Private labs in price war for H1N1 testing
The health ministry is yet to give private labs the go-ahead to test samples for H1N1 swine flu but a price war has already begun among the...
- Ranbaxy is eyeing buyouts in pathology labs business
SRL Ranbaxy is aggressively eyeing acquisitions in the pathology lab business. The pathology testing business of Ranbaxy group has formed a...